Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Marc Olesen, Leroy Hood, Paul Flicek, and Adam Siepel


DNANexus has appointed Marc Olesen to serve as president and chief operating officer.

Prior to joining DNANexus Olesen served as senior vice president and general manager of network and cloud security for McAfee. He also served as vice president of software-as-a-service for Mercury Interactive, which was acquired
during his tenure by Hewlett-Packard.

Olesen holds an AB in economics and an MS in industrial engineering from Stanford University.

Omicia has tapped Leroy Hood, the president and co-founder of the Institute for Systems Biology, and Paul Flicek, a team leader and senior scientist at the European Bioinformatics Institute, to serve on its scientific advisory board.

Adam Siepel, an associate professor of biological statistics and computational biology at Cornell University, has received a Guggenheim fellowship from the John Simon Guggenheim Memorial Foundation.

Siepel has developed tools that have been used in the identification of recombinant strains of HIV, the discovery of new human genes, and the characterization of the non-protein-coding regions of mammalian genomes.

He was one of 181 artists, scientists, and scholars chosen to receive fellowships from about 3,999 applications as part of the foundation’s 88th annual competition for the US and Canada.

Siepel will use the fellowship to support a sabbatical leave for the 2012-13 academic year, to be spent in Cambridge, UK, where he will work at the European Bioinformatics Institute.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.